Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

110.27 -2.21 (-1.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 404,731
Open 111.97
Bid (Size) 109.50 (1)
Ask (Size) 118.10 (1)
Prev. Close 112.48
Today's Range 109.56 - 111.97
52wk Range 95.49 - 148.06
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal. 
Via Investor's Business Daily
Topics Intellectual Property
JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) – An Undervalued Biopharmaceutical Stock Worth Watching
JAZZ Pharmaceuticals (NASDAQ:JAZZ) appears undervalued with strong profitability and decent growth, making it a candidate for value investors. Check the full analysis for details. 
Via Chartmill

Performance

YTD
-10.9%
-10.9%
1 Month
-0.2%
-0.2%
3 Month
+9.7%
+9.7%
6 Month
-9.2%
-9.2%
1 Year
+4.0%
+4.0%

More News

Read More
Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz
Via Benzinga
JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) – An Undervalued Biopharmaceutical Stock Worth Watching
Via Chartmill
The Analyst Verdict: Jazz Pharmaceuticals In The Eyes Of 11 Experts
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
Preview: Jazz Pharmaceuticals's Earnings
Via Benzinga
Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study
Via Benzinga
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – An Undervalued Biopharmaceutical Stock Worth Watching
Via Chartmill
JAZZ Q1 Earnings Call: Revenue and Profit Miss, Product Pipeline Drives Outlook
Via StockStory
Topics World Trade
Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Jazz Pharmaceuticals (NASDAQ:JAZZ) Misses Q1 Sales Targets
Via StockStory
Earnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect
Via StockStory
Despite its impressive fundamentals,JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) remains undervalued.
Via Chartmill
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): A Potential Undervalued Stock
Via Chartmill
3 Reasons to Sell JAZZ and 1 Stock to Buy Instead
Via StockStory
3 Small-Cap Stocks in the Doghouse
Via StockStory
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Where Jazz Pharmaceuticals Stands With Analysts
Via Benzinga
3 Value Stocks Skating on Thin Ice
Via StockStory
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
For those who appreciate value investing, JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) is a compelling option with its solid fundamentals.
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq – TURN)
From Brodsky & Smith LLC
Via GlobeNewswire
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga

Frequently Asked Questions

Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 110.27
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 07/11/25 04:00 PM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 6.87B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.